Dr. Willard Burks, M.D

NPI: 1619082310
Total Payments
$5,354
2024 Payments
$325.39
Companies
33
Transactions
384
Medicare Patients
8,142
Medicare Billing
$624,755

Payment Breakdown by Category

Food & Beverage$5,345 (99.8%)
Education$8.71 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,345 382 99.8%
Education $8.71 2 0.2%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,048 71 $0 (2024)
ABBVIE INC. $903.90 59 $0 (2024)
PFIZER INC. $668.92 93 $0 (2024)
GlaxoSmithKline, LLC. $483.83 29 $0 (2023)
Sunovion Pharmaceuticals Inc. $414.02 34 $0 (2022)
Janssen Pharmaceuticals, Inc $302.77 20 $0 (2018)
AstraZeneca Pharmaceuticals LP $276.10 10 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $200.55 7 $0 (2021)
Novartis Pharmaceuticals Corporation $144.66 3 $0 (2022)
SANOFI-AVENTIS U.S. LLC $111.72 9 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $325.39 20 ABBVIE INC. ($78.96)
2023 $803.65 51 AbbVie Inc. ($275.08)
2022 $872.72 53 ABBVIE INC. ($376.49)
2021 $610.93 44 AbbVie Inc. ($173.37)
2020 $242.58 12 Novo Nordisk Inc ($130.27)
2019 $329.50 47 Novo Nordisk Inc ($152.38)
2018 $812.96 59 Novo Nordisk Inc ($210.24)
2017 $1,356 98 Janssen Pharmaceuticals, Inc ($262.56)

All Payment Transactions

384 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/12/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $13.15 General
Category: ANTI-ANXIETY
11/04/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.18 General
Category: Diabetes
09/10/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.80 General
Category: Diabetes
09/09/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $16.43 General
Category: Heart Failure and Hypertension
08/27/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $14.74 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/08/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.37 General
Category: Respiratory
07/25/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.08 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/10/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.39 General
Category: NEUROSCIENCE
07/09/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.10 General
Category: Diabetes
06/20/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.30 General
Category: Cardiovascular and Metabolism
06/13/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $17.98 General
Category: NEUROSCIENCE
05/23/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.19 General
Category: Cardiovascular
04/16/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $21.27 General
Category: NEUROSCIENCE
03/27/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $15.35 General
Category: Cardiology
03/14/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $17.62 General
Category: ANTI-ANXIETY
03/13/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $17.57 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/08/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.00 General
Category: Cardiovascular and Metabolism
02/22/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.97 General
Category: Diabetes
02/05/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $17.32 General
Category: NEUROSCIENCE
01/08/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.58 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/29/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY Food and Beverage In-kind items and services $5.92 General
Category: RESPIRATORY
12/20/2023 AbbVie Inc. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $2.60 General
Category: NEUROSCIENCE
12/14/2023 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $20.76 General
Category: ANTI-ANXIETY
12/12/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.39 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/12/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.99 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 764 1,924 $249,704 $112,140
2022 30 1,957 3,633 $307,571 $150,841
2021 39 2,722 6,247 $385,563 $196,050
2020 42 2,699 6,460 $362,500 $165,725
Total Patients
8,142
Total Services
18,264
Medicare Billing
$624,755
Procedure Codes
124

All Medicare Procedures & Services

124 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 268 941 $94,100 $41,259 43.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 189 467 $65,380 $27,391 41.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 60 206 $36,050 $17,397 48.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Facility 2023 118 118 $20,650 $13,772 66.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 54 78 $19,890 $5,582 28.1%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 27 34 $4,080 $2,005 49.1%
99496 Transitional care management services for problem of high complexity Facility 2023 13 13 $2,860 $1,820 63.6%
99307 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes Facility 2023 12 44 $3,300 $1,270 38.5%
99495 Transitional care management services for problem of at least moderate complexity Facility 2023 12 12 $2,580 $1,233 47.8%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Facility 2023 11 11 $814.00 $410.96 50.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 263 801 $82,469 $42,054 51.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 183 340 $52,335 $24,640 47.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 125 223 $31,220 $15,622 50.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 166 258 $25,800 $12,477 48.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 61 153 $24,861 $11,457 46.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Facility 2022 68 68 $11,900 $8,061 67.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 48 48 $8,955 $5,735 64.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 50 79 $18,017 $4,530 25.1%
99495 Transitional care management services for problem of moderate complexity Office 2022 25 28 $5,885 $4,200 71.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 27 70 $7,966 $3,669 46.1%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 40 55 $6,180 $2,895 46.8%
90662 Influenza vaccine split virus, preservative free Facility 2022 44 44 $2,904 $2,846 98.0%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 35 41 $2,665 $1,819 68.2%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2022 83 102 $2,550 $1,359 53.3%
G0008 Administration of influenza virus vaccine Facility 2022 43 43 $1,665 $1,130 67.9%

About Dr. Willard Burks, M.D

Dr. Willard Burks, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619082310.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Willard Burks, M.D has received a total of $5,354 in payments from pharmaceutical and medical device companies, with $325.39 received in 2024. These payments were reported across 384 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,345).

As a Medicare-enrolled provider, Burks has provided services to 8,142 Medicare beneficiaries, totaling 18,264 services with total Medicare billing of $624,755. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Wynne, AR
  • Active Since 08/20/2006
  • Last Updated 03/29/2012
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1619082310

Products in Payments

  • UBRELVY (Drug) $478.27
  • Ozempic (Drug) $439.39
  • QULIPTA (Drug) $357.07
  • TRELEGY ELLIPTA (Drug) $332.73
  • ELIQUIS (Drug) $317.86
  • FARXIGA (Drug) $200.74
  • CHANTIX (Drug) $195.85
  • XARELTO (Drug) $189.93
  • Victoza (Drug) $176.00
  • Tresiba (Drug) $171.35
  • JARDIANCE (Drug) $168.52
  • GEMTESA (Drug) $158.89
  • ENTRESTO (Drug) $144.66
  • RYBELSUS (Drug) $142.74
  • AREXVY (Drug) $123.75
  • INVOKANA (Drug) $112.84
  • Ranexa (Drug) $100.00
  • LYRICA (Drug) $97.15
  • Utibron (Drug) $95.50
  • PREVNAR - 13 (Biological) $94.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Wynne